Gerhard Opelz1, Bernd Döhler. 1. 1 Department of Transplantation, Immunology, University of Heidelberg, Heidelberg, Germany.
Abstract
BACKGROUND: Evidence is limited regarding the effect of stopping smoking before kidney transplantation. METHODS: Collaborative Transplant Study data from 46 548 recipients of first kidney transplants (1995-2012) were analyzed to 10 years after transplantation. RESULTS: Compared with patients who had never smoked (n = 31,462), patients who stopped smoking before transplantation (n = 10,291) only had a modestly increased risk of all-cause graft failure (hazard ratio [HR], 1.1; 95% confidence interval [95% CI], 1.0-1.1; P < 0.001) or death (HR,1.1; 95% CI, 1.0-1.2; P < 0.001) and a similar risk of death-censored graft failure (HR,1.0, 95% CI, 1.0-1.1; P = 0.19), but a 40% increase in death from malignancy (HR, 1.4; 95% CI, 1.2-1.7; P < 0.001). The risk of events was generally markedly higher in patients who continued to smoke (n = 4795) versus those who had stopped. For tumors of the lip, oral cavity and pharynx, digestive organs, respiratory tract, female genitalia and urinary tract, HR values increased significantly from never-smoked to former smokers to current smokers. The risk of respiratory tumors or cervical cancer was approximately halved when smoking was stopped versus continued. CONCLUSIONS: This large series provides clear evidence that patients who stop smoking before transplantation experience substantial benefits, including a substantial reduction in certain types of malignancy.
BACKGROUND: Evidence is limited regarding the effect of stopping smoking before kidney transplantation. METHODS: Collaborative Transplant Study data from 46 548 recipients of first kidney transplants (1995-2012) were analyzed to 10 years after transplantation. RESULTS: Compared with patients who had never smoked (n = 31,462), patients who stopped smoking before transplantation (n = 10,291) only had a modestly increased risk of all-cause graft failure (hazard ratio [HR], 1.1; 95% confidence interval [95% CI], 1.0-1.1; P < 0.001) or death (HR,1.1; 95% CI, 1.0-1.2; P < 0.001) and a similar risk of death-censored graft failure (HR,1.0, 95% CI, 1.0-1.1; P = 0.19), but a 40% increase in death from malignancy (HR, 1.4; 95% CI, 1.2-1.7; P < 0.001). The risk of events was generally markedly higher in patients who continued to smoke (n = 4795) versus those who had stopped. For tumors of the lip, oral cavity and pharynx, digestive organs, respiratory tract, female genitalia and urinary tract, HR values increased significantly from never-smoked to former smokers to current smokers. The risk of respiratory tumors or cervical cancer was approximately halved when smoking was stopped versus continued. CONCLUSIONS: This large series provides clear evidence that patients who stop smoking before transplantation experience substantial benefits, including a substantial reduction in certain types of malignancy.
Authors: Katrin Birkefeld; Maximilian Bauer-Hohmann; Felix Klewitz; Eva-Marie Kyaw Tha Tun; Uwe Tegtbur; Lars Pape; Lena Schiffer; Mario Schiffer; Martina de Zwaan; Mariel Nöhre Journal: J Clin Psychol Med Settings Date: 2022-02-23
Authors: Richelle N DeBlasio; Larissa Myaskovsky; Andrea F DiMartini; Emilee Croswell; Donna M Posluszny; Chethan Puttarajappa; Galen E Switzer; Ron Shapiro; Annette J DeVito Dabbs; Amit D Tevar; Sundaram Hariharan; Mary Amanda Dew Journal: Transplantation Date: 2022-04-01 Impact factor: 5.385
Authors: Muhammad Abdul Mabood Khalil; Jackson Tan; Said Khamis; Muhammad AshhadUllah Khalil; Rabeea Azmat; Arslan Rahat Ullah Journal: Adv Med Date: 2017-07-27
Authors: Manuel Rodríguez-Perálvarez; Jordi Colmenero; Antonio González; Mikel Gastaca; Anna Curell; Aránzazu Caballero-Marcos; Ana Sánchez-Martínez; Tommaso Di Maira; José Ignacio Herrero; Carolina Almohalla; Sara Lorente; Antonio Cuadrado-Lavín; Sonia Pascual; María Ángeles López-Garrido; Rocío González-Grande; Antonio Gómez-Orellana; Rafael Alejandre; Javier Zamora-Olaya; Carmen Bernal-Bellido Journal: Am J Transplant Date: 2022-03-31 Impact factor: 9.369
Authors: Torbjørn Fossum Heldal; Anders Åsberg; Thor Ueland; Anna Varberg Reisaeter; Søren E Pischke; Tom Eirik Mollnes; Pål Aukrust; Anders Hartmann; Kristian Heldal; Trond Jenssen Journal: Am J Transplant Date: 2022-04-29 Impact factor: 9.369